In line with this report, Sideras et al. confirmed that low expression of PD-L1 and low CD8+ predict extremely poor HCC-specific survival in a cohort of 154 patients with resected liver tumors [37]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.